The molecular respiratory panels market size is projected to be worth US$ 1.1 billion in 2023. The market is likely to surpass US$ 2.0 billion by 2033 at a CAGR of 6.3% during the forecast period. The rising incidence of respiratory infections, including viral outbreaks such as influenza and the COVID-19 pandemic, is a major driving force behind the demand for molecular respiratory panels’. These panels’ offer rapid and accurate diagnosis, enabling timely treatment and infection control measures.
Other Drivers Propelling the Demand for Molecular Respiratory Panels Market include:
Challenges for Companies /Manufacturers in the Molecular Respiratory Panels Market:
Opportunities in the Molecular Respiratory Panels Market Industry:
Latest Trends in the Molecular Respiratory Panels Market:
| Attributes | Details |
|---|---|
| Molecular Respiratory Panels Market Size (2023) | US$ 1.1 billion |
| Molecular Respiratory Panels Market Projected Size (2033) | US$ 2.0 billion |
| Value CAGR (2023 to 2033) | 6.3% |
Don't pay for what you don't need
Customize your report by selecting specific countries or regions and save 30%!
From 2017 to 2022, the global molecular respiratory panels’ market experienced a CAGR of 9.2%, reaching a market size of US$ 1.1 million in 2023.
From 2017 to 2022, the global molecular respiratory panels’’ market industry witnessed steady growth due to the increased prevalence of respiratory illnesses and technological advancements. Significant advances in molecular diagnostic technology have occurred throughout the years, including the creation of polymerase chain reaction (PCR) and other nucleic acid amplification techniques. These technological improvements have enhanced the sensitivity, specificity, and multiplexing capabilities of molecular respiratory panels’, which has contributed to the growth of the market.
Respiratory diseases, such as influenza, respiratory syncytial virus (RSV), and other respiratory pathogens, have long been a source of worry across the world. The growing prevalence of these illnesses has increased need for reliable and speedy diagnostic tests, propelling the molecular respiratory panels’ market forward.
Future Forecast for Molecular Respiratory Panels Market Industry:
Looking ahead, the global molecular respiratory panels’’ market industry is expected to rise at a CAGR of 6.3% from 2023 to 2033. During the forecast period, the market size is expected to reach US$ 2.0 billion by 2033.
The molecular respiratory panels’’ market industry is expected to continue its growth trajectory from 2023 to 2033. As the benefits and capabilities of molecular respiratory panels’ become more generally recognized, healthcare practitioners are likely to become more aware and employ them. The requirement for accurate and quick diagnosis, as well as infection management and monitoring, will drive the expansion of the molecular respiratory panel market.
The requirement for quick results and decentralized testing will push the need for point-of-care testing to expand further. Molecular respiratory panels’ that may be conducted at the point of treatment, such as in clinics or emergency rooms, are expected to acquire market traction.
| Country | The United States |
|---|---|
| Market Size (US$ Million) by End of Forecast Period (2033) | US$ 575.6 million |
| CAGR % 2023 to End of Forecast (2033) | 7.0% |
The molecular respiratory panels’’ market industry in the United States is expected to reach a market size of US$ 575.6 million by 2033, expanding at a CAGR of 7.0%. The incidence of chronic respiratory disorders in the nation is increasing, which is driving up demand for the industry. For instance, the USA Centers for Disease Control and Prevention (CDC) 2022 report showed that in 8 out of 10 public health districts in the USA, the prevalence of respiratory syncytial virus (RSV) is rising.
| Country | The United Kingdom |
|---|---|
| Market Size (US$ Million) by End of Forecast Period (2033) | US$ 73.6 million |
| CAGR % 2023 to End of Forecast (2033) | 5.3% |
The molecular respiratory panels’’ market industry in the United Kingdom is expected to reach a market share of US$ 73.6 million, expanding at a CAGR of 5.3% during the forecast period. Strict laws for the mining sector increase the usage of the molecular respiratory panels’. In the EU there are around 53,000 people employed by coal power stations. The EU’s regulatory body also conducts routine checkups of these workers, which boosts demand for molecular respiratory panels’.
| Country | China |
|---|---|
| Market Size (US$ Million) by End of Forecast Period (2033) | US$ 180.6 million |
| CAGR % 2023 to End of Forecast (2033) | 7.7% |
The molecular respiratory panels’’ market industry in China is anticipated to reach a market size of US$ 180.6 million, moving at a CAGR of 7.7% during the forecast period. The molecular respiratory panel’s market industry in China is expected to grow prominently due to the increasing population with respiratory illness. China has a big population, and respiratory illnesses such as influenza, Respiratory syncytial (RSV), and other respiratory pathogens are common. The rising prevalence of these illnesses is raising the requirement for precise and effective diagnostic techniques such as molecular respiratory panels’.
| Country | Japan |
|---|---|
| Market Size (US$ Million) by End of Forecast Period (2033) | US$ 126.0 million |
| CAGR % 2023 to End of Forecast (2033) | 7.4% |
The molecular respiratory panels’ market industry in Japan is estimated to reach a market size of US$ 126.0 million by 2033, thriving at a CAGR of 7.4%. The market in Japan is predicted to grow because of high geriatric population. Japan has one of the world's oldest populations, and respiratory illnesses such as pneumonia and influenza are widespread among the elderly. The growing older population in Japan, as well as the requirement for precise respiratory illness detection, are projected to boost demand for molecular respiratory panels.
| Country | South Korea |
|---|---|
| Market Size (US$ Million) by End of Forecast Period (2033) | US$ 49.3 million |
| CAGR % 2023 to End of Forecast (2033) | 6.8% |
The molecular respiratory panels’ market industry in South Korea is expected to reach a market size of US$ 49.3 million, expanding at a CAGR of 6.8% during the forecast period. In the past, South Korea has had outbreaks of respiratory illnesses such as MERS (Middle East Respiratory Syndrome) and COVID-19. These incidents have raised public awareness of respiratory illnesses, resulting in a greater demand for reliable market data.
Principal Consultant
The multiplex panels is to dominate the molecular respiratory panels’ market industry with a market share of 50.4% in 2022. A multiplex molecular diagnostic platform would be a crucial component of a successful respiratory diagnostics method. For the identification of respiratory infections, NADT methods such as loop-mediated isothermal amplification and nucleic acid sequence-based amplification have been utilized.
Multiplexing, in which numerous targets are evaluated at the same time, is often used in PCR-based assays and offers substantial advantages in terms of efficiency and pathogen coverage over single-pathogen tests.
Diagnostic use is dominating the molecular respiratory panels’ market industry with market share of 65.8% in 2022. Molecular respiratory panels are generally used for diagnostic reasons since they are designed to detect and identify respiratory pathogens at the molecular level, delivering accurate and speedy findings for respiratory infection diagnosis.
Reverse transcription polymerase chain reaction (RT-PCR) is dominating the molecular respiratory panels’ market with the market share of 47.8% in 2022. RT-PCR may identify very low quantities of viral genetic material in patient samples. This great sensitivity enables for the early diagnosis of viral infections, even when the viral load is low in the early stages of the disease. It facilitates accurate diagnosis and patient management. This technique's great sensitivity is particularly appealing to healthcare professionals and individuals seeking to diagnose.
The diagnostic centers dominating the molecular respiratory panels’ market with the market share of 38.1% in 2022. Diagnostic centers often utilize molecular respiratory panels as part of their comprehensive testing services for respiratory infections. These panels offer several advantages, such as the ability to simultaneously test for multiple respiratory pathogens in a single assay, high sensitivity and specificity, and rapid turnaround times.
The molecular respiratory panel sector is aggressively competitive, with many companies fighting for market dominance. Key players in the molecular respiratory panels market employ various strategies to stay competitive and maintain their market position.
Key Strategies Used by the Participants
Key players invest in research and development activities to continuously improve their molecular respiratory panel products. By offering innovative and advanced products, companies can attract customers and differentiate themselves from competitors.
Key players form strategic partnerships and collaborations with other companies, academic institutions, and research organizations. These partnerships facilitate the exchange of knowledge, resources, and technologies, leading to the development of new products and solutions.
Companies focus on expanding their presence in different geographic regions. This involves establishing distribution channels, partnerships with local distributors, and obtaining necessary regulatory approvals in target markets.
Companies in the market may engage in mergers or acquisitions to consolidate their product portfolio, acquire new technologies, these strategic moves allow companies to enter new market segments, gain access to novel products or intellectual property, and achieve synergies in terms of research, manufacturing, or distributions.
Get the data you need at a Fraction of the cost
Personalize your report by choosing insights you need
and save 40%!
Key Developments in the Molecular Respiratory Panels Market:
The market is anticipated to expand at a 6.3% CAGR from 2023 to 2033.
The market totals US$ 1.1 billion in 2023.
Asia Pacific is expected to be a lucrative market.
High equipment limits the market growth.
From 2017 to 2022, the market held a 9.2% CAGR.
1. Executive Summary
1.1. Global Market Outlook
1.2. Demand Side Trends
1.3. Supply Side Trends
1.4. Analysis and Recommendations
2. Market Overview
2.1. Market Coverage / Taxonomy
2.2. Market Definition / Scope / Limitations
2.3. Inclusions and Exclusions
3. Key Market Trends
3.1. Key Trends Impacting the Market
3.2. Product Innovation / Development Trends
4. Value Added Insights
4.1. Product Adoption / Usage Analysis
4.2. Product Features/ USPs
4.3. Technological Roadmap
4.4. Recent Product Approvals/Launches
4.5. Regulatory Landscape
4.6. PESTEL Analysis
4.7. Porter’s Analysis
5. Market Background
5.1. Macro-Economic Factors
5.1.1. Global Healthcare Expenditure Outlook
5.1.2. Global Medical Device Outlook
5.1.3. Global Life Expectancy Outlook
5.2. Forecast Factors - Relevance & Impact
5.2.1. Key Player’s Historic Growth
5.2.2. Growing Awareness about Respiratory Diseases
5.2.3. Favourable Government Regulations
5.2.4. Technological Advancement
5.2.5. Increasing Prevalence of Respiratory Diseases
5.2.6. Frequency of Product Approvals
5.3. Dynamics
5.3.1. Drivers
5.3.2. Restraints
5.3.3. Opportunity Analysis
6. Global Market Volume (in Units) Analysis 2017 to 2022 and Forecast, 2023 to 2033
6.1. Historical Volume (in Units) Analysis, 2017 to 2022
6.2. Current and Future Volume (in Units) Projections, 2023 to 2033
6.2.1. Y-o-Y Growth Trend Analysis
7. Global Market - Pricing Analysis
7.1. Regional Pricing Analysis By Panel Type
7.2. Pricing Break-up
7.2.1. Manufacturer Level Pricing
7.2.2. Distributor Level Pricing
7.3. Global Average Pricing Analysis Benchmark
7.4. Pricing Assumptions
8. Global Market Demand (in Value or Size in US$ Mn) Analysis 2017 to 2022 and Forecast, 2023 to 2033
8.1. Historical Market Value (US$ Million) Analysis, 2017 to 2022
8.2. Current and Future Market Value (US$ Million) Projections, 2023 to 2033
8.2.1. Y-o-Y Growth Trend Analysis
8.2.2. Absolute $ Opportunity Analysis
9. Global Market Analysis 2017 to 2022 and Forecast 2023 to 2033, By Panel Type
9.1. Introduction / Key Findings
9.2. Historical Market Size (US$ Million) and Volume (Units) Analysis By Panel Type, 2017 to 2022
9.3. Current and Future Market Size (US$ Million) and Volume (Units) Analysis and Forecast By Panel Type, 2023 to 2033
9.3.1. Multiplex Panels
9.3.2. Syndromic Panels
9.3.3. Targeted Panels
9.4. Market Attractiveness Analysis By Panel Type
10. Global Market Analysis 2017 to 2022 and Forecast 2023 to 2033, By Usage Type
10.1. Introduction / Key Findings
10.2. Historical Market Size (US$ Million) Analysis By Usage Type, 2017 to 2022
10.3. Current and Future Market Size (US$ Million) Analysis and Forecast By Usage Type, 2023 to 2033
10.3.1. Diagnostic Use
10.3.2. Research Use
10.4. Market Attractiveness Analysis By Usage Type
11. Global Market Analysis 2017 to 2022 and Forecast 2023 to 2033, By Technique
11.1. Introduction / Key Findings
11.2. Historical Market Size (US$ Million) Analysis By Technique, 2017 to 2022
11.3. Current and Future Market Size (US$ Million) Analysis and Forecast By Technique, 2023 to 2033
11.3.1. Polymerase Chain Reaction (PCR)
11.3.2. Reverse Transcription Polymerase Chain Reaction (RT-PCR)
11.3.3. Real-time Polymerase Chain Reaction (qPCR)
11.3.4. Next-Generation Sequencing (NGS)
11.4. Market Attractiveness Analysis By Technique
12. Global Market Analysis 2017 to 2022 and Forecast 2023 to 2033, By End User
12.1. Introduction / Key Findings
12.2. Historical Market Size (US$ Million) Analysis By End User, 2017 to 2022
12.3. Current and Future Market Size (US$ Million) Analysis and Forecast By End User, 2023 to 2033
12.3.1. Hospitals
12.3.2. Diagnostic Centers
12.3.3. Academic & Research Institutions
12.3.4. Ambulatory Diagnostic Centers
12.4. Market Attractiveness Analysis By End User
13. Global Market Analysis 2017 to 2022 and Forecast 2023 to 2033, by Region
13.1. Introduction
13.2. Historical Market Size (US$ Million) and Volume (Units) Analysis By Region, 2017 to 2022
13.3. Current and Future Market Size (US$ Million) and Volume (Units) Analysis and Forecast By Region, 2023 to 2033
13.3.1. North America
13.3.2. Latin America
13.3.3. Europe
13.3.4. South Asia
13.3.5. East Asia
13.3.6. Oceania
13.3.7. Middle East and Africa (MEA)
13.4. Market Attractiveness Analysis By Region
14. North America Market Analysis 2017 to 2022 and Forecast 2023 to 2033
14.1. Introduction
14.2. Historical Market Size (US$ Million) and Volume (Units) Analysis By Market Taxonomy, 2017 to 2022
14.3. Current and Future Market Size (US$ Million) and Volume (Units) Analysis and Forecast By Market Taxonomy, 2023 to 2033
14.3.1. By Country
14.3.1.1. USA
14.3.1.2. Canada
14.3.2. By Panel Type
14.3.3. By Usage
14.3.4. By Technique
14.3.5. By End User
14.4. Market Attractiveness Analysis
14.4.1. By Country
14.4.2. By Panel Type
14.4.3. By Usage
14.4.4. By Technique
14.4.5. By End User
14.5. Country Level Analysis & Forecast
14.5.1. USA Market Analysis
14.5.1.1. Introduction
14.5.1.2. Market Analysis and Forecast by Market Taxonomy
14.5.1.2.1. By Panel Type
14.5.1.2.2. By Usage
14.5.1.2.3. By Technique
14.5.1.2.4. By End User
14.5.2. Canada Market Analysis
14.5.2.1. Introduction
14.5.2.2. Market Analysis and Forecast by Market Taxonomy
14.5.2.2.1. By Panel Type
14.5.2.2.2. By Usage
14.5.2.2.3. By Technique
14.5.2.2.4. By End User
14.6. Market Trends
14.7. Key Market Participants - Intensity Mapping
14.8. Drivers and Restraints - Impact Analysis
15. Latin America Market Analysis 2017 to 2022 and Forecast 2023 to 2033
15.1. Introduction
15.2. Historical Market Size (US$ Million) and Volume (Units) Analysis By Market Taxonomy, 2017 to 2022
15.3. Current and Future Market Size (US$ Million) and Volume (Units) Analysis and Forecast By Market Taxonomy, 2023 to 2033
15.3.1. By Country
15.3.1.1. Brazil
15.3.1.2. Mexico
15.3.1.3. Argentina
15.3.1.4. Rest of Latin America
15.3.2. By Panel Type
15.3.3. By Usage
15.3.4. By Technique
15.3.5. By End User
15.4. Market Attractiveness Analysis
15.4.1. By Country
15.4.2. By Panel Type
15.4.3. By Usage
15.4.4. By Technique
15.4.5. By End User
15.5. Country Level Analysis & Forecast
15.5.1. Brazil Market Analysis
15.5.1.1. Introduction
15.5.1.2. Market Analysis and Forecast by Market Taxonomy
15.5.1.2.1. By Panel Type
15.5.1.2.2. By Usage
15.5.1.2.3. By Technique
15.5.1.2.4. By End User
15.5.2. Mexico Market Analysis
15.5.2.1. Introduction
15.5.2.2. Market Analysis and Forecast by Market Taxonomy
15.5.2.2.1. By Panel Type
15.5.2.2.2. By Usage
15.5.2.2.3. By Technique
15.5.2.2.4. By End User
15.5.3. Argentina Market Analysis
15.5.3.1. Introduction
15.5.3.2. Market Analysis and Forecast by Market Taxonomy
15.5.3.2.1. By Panel Type
15.5.3.2.2. By Usage
15.5.3.2.3. By Technique
15.5.3.2.4. By End User
15.6. Market Trends
15.7. Key Market Participants - Intensity Mapping
15.8. Drivers and Restraints - Impact Analysis
16. Europe Market Analysis 2017 to 2022 and Forecast 2023 to 2033
16.1. Introduction
16.2. Historical Market Size (US$ Million) and Volume (Units) Analysis By Market Taxonomy, 2017 to 2022
16.3. Current and Future Market Size (US$ Million) and Volume (Units) Analysis and Forecast By Market Taxonomy, 2023 to 2033
16.3.1. By Country
16.3.1.1. Germany
16.3.1.2. France
16.3.1.3. Italy
16.3.1.4. UK
16.3.1.5. Spain
16.3.1.6. Russia
16.3.1.7. BENELUX
16.3.1.8. Rest of Europe
16.3.2. By Panel Type
16.3.3. By Usage
16.3.4. By Technique
16.3.5. By End User
16.4. Market Attractiveness Analysis
16.4.1. By Country
16.4.2. By Panel Type
16.4.3. By Usage
16.4.4. By Technique
16.4.5. By End User
16.5. Country Level Analysis & Forecast
16.5.1. Germany Market Analysis
16.5.1.1. Introduction
16.5.1.2. Market Analysis and Forecast by Market Taxonomy
16.5.1.2.1. By Panel Type
16.5.1.2.2. By Usage
16.5.1.2.3. By Technique
16.5.1.2.4. By End User
16.5.2. France Market Analysis
16.5.2.1. Introduction
16.5.2.2. Market Analysis and Forecast by Market Taxonomy
16.5.2.2.1. By Panel Type
16.5.2.2.2. By Usage
16.5.2.2.3. By Technique
16.5.2.2.4. By End User
16.5.3. Italy Market Analysis
16.5.3.1. Introduction
16.5.3.2. Market Analysis and Forecast by Market Taxonomy
16.5.3.2.1. By Panel Type
16.5.3.2.2. By Usage
16.5.3.2.3. By Technique
16.5.3.2.4. By End User
16.5.4. UK Market Analysis
16.5.4.1. Introduction
16.5.4.2. Market Analysis and Forecast by Market Taxonomy
16.5.4.2.1. By Panel Type
16.5.4.2.2. By Usage
16.5.4.2.3. By Technique
16.5.4.2.4. By End User
16.5.5. Spain Market Analysis
16.5.5.1. Introduction
16.5.5.2. Market Analysis and Forecast by Market Taxonomy
16.5.5.2.1. By Panel Type
16.5.5.2.2. By Usage
16.5.5.2.3. By Technique
16.5.5.2.4. By End User
16.5.6. Russia Market Analysis
16.5.6.1. Introduction
16.5.6.2. Market Analysis and Forecast by Market Taxonomy
16.5.6.2.1. By Panel Type
16.5.6.2.2. By Usage
16.5.6.2.3. By Technique
16.5.6.2.4. By End User
16.5.7. BENELUX Market Analysis
16.5.7.1. Introduction
16.5.7.2. Market Analysis and Forecast by Market Taxonomy
16.5.7.2.1. By Panel Type
16.5.7.2.2. By Usage
16.5.7.2.3. By Technique
16.5.7.2.4. By End User
16.6. Market Trends
16.7. Key Market Participants - Intensity Mapping
16.8. Drivers and Restraints - Impact Analysis
17. South Asia Market Analysis 2017 to 2022 and Forecast 2023 to 2033
17.1. Introduction
17.2. Historical Market Size (US$ Million) and Volume (Units) Analysis By Market Taxonomy, 2017 to 2022
17.3. Current and Future Market Size (US$ Million) and Volume (Units) Analysis and Forecast By Market Taxonomy, 2023 to 2033
17.3.1. By Country
17.3.1.1. India
17.3.1.2. Thailand
17.3.1.3. Indonesia
17.3.1.4. Malaysia
17.3.1.5. Rest of South Asia
17.3.2. By Panel Type
17.3.3. By Usage
17.3.4. By Technique
17.3.5. By End User
17.4. Market Attractiveness Analysis
17.4.1. By Country
17.4.2. By Panel Type
17.4.3. By Usage
17.4.4. By Technique
17.4.5. By End User
17.5. Country Level Analysis & Forecast
17.5.1. India Market Analysis
17.5.1.1. Introduction
17.5.1.2. Market Analysis and Forecast by Market Taxonomy
17.5.1.2.1. By Panel Type
17.5.1.2.2. By Usage
17.5.1.2.3. By Technique
17.5.1.2.4. By End User
17.5.2. Thailand Market Analysis
17.5.2.1. Introduction
17.5.2.2. Market Analysis and Forecast by Market Taxonomy
17.5.2.2.1. By Panel Type
17.5.2.2.2. By Usage
17.5.2.2.3. By Technique
17.5.2.2.4. By End User
17.5.3. Indonesia Market Analysis
17.5.3.1. Introduction
17.5.3.2. Market Analysis and Forecast by Market Taxonomy
17.5.3.2.1. By Panel Type
17.5.3.2.2. By Usage
17.5.3.2.3. By Technique
17.5.3.2.4. By End User
17.5.4. Malaysia Market Analysis
17.5.4.1. Introduction
17.5.4.2. Market Analysis and Forecast by Market Taxonomy
17.5.4.2.1. By Panel Type
17.5.4.2.2. By Usage
17.5.4.2.3. By Technique
17.5.4.2.4. By End User
17.6. Market Trends
17.7. Key Market Participants - Intensity Mapping
17.8. Drivers and Restraints - Impact Analysis
18. East Asia Market Analysis 2017 to 2022 and Forecast 2023 to 2033
18.1. Introduction
18.2. Historical Market Size (US$ Million) and Volume (Units) Analysis By Market Taxonomy, 2017 to 2022
18.3. Current and Future Market Size (US$ Million) and Volume (Units) Analysis and Forecast By Market Taxonomy, 2023 to 2033
18.3.1. By Country
18.3.1.1. China
18.3.1.2. Japan
18.3.1.3. South Korea
18.3.2. By Panel Type
18.3.3. By Usage
18.3.4. By Technique
18.3.5. By End User
18.4. Market Attractiveness Analysis
18.4.1. By Country
18.4.2. By Panel Type
18.4.3. By Usage
18.4.4. By Technique
18.4.5. By End User
18.5. Country Level Analysis & Forecast
18.5.1. China Market Analysis
18.5.1.1. Introduction
18.5.1.2. Market Analysis and Forecast by Market Taxonomy
18.5.1.2.1. By Panel Type
18.5.1.2.2. By Usage
18.5.1.2.3. By Technique
18.5.1.2.4. By End User
18.5.2. Japan Market Analysis
18.5.2.1. Introduction
18.5.2.2. Market Analysis and Forecast by Market Taxonomy
18.5.2.2.1. By Panel Type
18.5.2.2.2. By Usage
18.5.2.2.3. By Technique
18.5.2.2.4. By End User
18.5.3. South Korea Market Analysis
18.5.3.1. Introduction
18.5.3.2. Market Analysis and Forecast by Market Taxonomy
18.5.3.2.1. By Panel Type
18.5.3.2.2. By Usage
18.5.3.2.3. By Technique
18.5.3.2.4. By End User
18.6. Market Trends
18.7. Key Market Participants - Intensity Mapping
18.8. Drivers and Restraints - Impact Analysis
19. Oceania Market Analysis 2017 to 2022 and Forecast 2023 to 2033
19.1. Introduction
19.2. Historical Market Size (US$ Million) and Volume (Units) Analysis By Market Taxonomy, 2017 to 2022
19.3. Current and Future Market Size (US$ Million) and Volume (Units) Analysis and Forecast By Market Taxonomy, 2023 to 2033
19.3.1. By Country
19.3.1.1. Australia
19.3.1.2. New Zealand
19.3.2. By Panel Type
19.3.3. By Usage
19.3.4. By Technique
19.3.5. By End User
19.4. Market Attractiveness Analysis
19.4.1. By Country
19.4.2. By Panel Type
19.4.3. By Usage
19.4.4. By Technique
19.4.5. By End User
19.5. Country Level Analysis & Forecast
19.5.1. Australia Market Analysis
19.5.1.1. Introduction
19.5.1.2. Market Analysis and Forecast by Market Taxonomy
19.5.1.2.1. By Panel Type
19.5.1.2.2. By Usage
19.5.1.2.3. By Technique
19.5.1.2.4. By End User
19.5.2. New Zealand Market Analysis
19.5.2.1. Introduction
19.5.2.2. Market Analysis and Forecast by Market Taxonomy
19.5.2.2.1. By Panel Type
19.5.2.2.2. By Usage
19.5.2.2.3. By Technique
19.5.2.2.4. By End User
19.6. Market Trends
19.7. Key Market Participants - Intensity Mapping
19.8. Drivers and Restraints - Impact Analysis
20. Middle East and Africa Market Analysis 2017 to 2022 and Forecast 2023 to 2033
20.1. Introduction
20.2. Historical Market Size (US$ Million) and Volume (Units) Analysis By Market Taxonomy, 2017 to 2022
20.3. Current and Future Market Size (US$ Million) and Volume (Units) Analysis and Forecast By Market Taxonomy, 2023 to 2033
20.3.1. By Country
20.3.1.1. GCC Countries
20.3.1.2. Türkiye
20.3.1.3. Northern Africa
20.3.1.4. South Africa
20.3.1.5. Rest of Middle East and Africa
20.3.2. By Panel Type
20.3.3. By Usage
20.3.4. By Technique
20.3.5. By End User
20.4. Market Attractiveness Analysis
20.4.1. By Country
20.4.2. By Panel Type
20.4.3. By Usage
20.4.4. By Technique
20.4.5. By End User
20.5. Country Level Analysis & Forecast
20.5.1. GCC Countries Market Analysis
20.5.1.1. Introduction
20.5.1.2. Market Analysis and Forecast by Market Taxonomy
20.5.1.2.1. By Panel Type
20.5.1.2.2. By Usage
20.5.1.2.3. By Technique
20.5.1.2.4. By End User
20.5.2. Türkiye Market Analysis
20.5.2.1. Introduction
20.5.2.2. Market Analysis and Forecast by Market Taxonomy
20.5.2.2.1. By Panel Type
20.5.2.2.2. By Usage
20.5.2.2.3. By Technique
20.5.2.2.4. By End User
20.5.3. Northern Africa Market Analysis
20.5.3.1. Introduction
20.5.3.2. Market Analysis and Forecast by Market Taxonomy
20.5.3.2.1. By Panel Type
20.5.3.2.2. By Usage
20.5.3.2.3. By Technique
20.5.3.2.4. By End User
20.5.4. South Africa Market Analysis
20.5.4.1. Introduction
20.5.4.2. Market Analysis and Forecast by Market Taxonomy
20.5.4.2.1. By Panel Type
20.5.4.2.2. By Usage
20.5.4.2.3. By Technique
20.5.4.2.4. By End User
20.6. Market Trends
20.7. Key Market Participants - Intensity Mapping
20.8. Drivers and Restraints - Impact Analysis
21. Market Structure Analysis
21.1. Market Analysis by Tier of Companies
21.2. Market Share Analysis of Top Players
21.3. Market Presence Analysis
22. Competition Analysis
22.1. Competition Dashboard
22.2. Competition Benchmarking
22.3. Competition Deep Dive
22.3.1. Roche Diagnostics
22.3.1.1. Overview
22.3.1.2. Product Portfolio
22.3.1.3. Key Financials
22.3.1.4. Sales Footprint
22.3.1.5. SWOT Analysis
22.3.1.6. Strategy Overview
22.3.1.6.1. Marketing Strategy
22.3.1.6.2. Product Strategy
22.3.1.6.3. Channel Strategy
22.3.2. Siemens Healthineers
22.3.2.1. Overview
22.3.2.2. Product Portfolio
22.3.2.3. Key Financials
22.3.2.4. Sales Footprint
22.3.2.5. SWOT Analysis
22.3.2.6. Strategy Overview
22.3.2.6.1. Marketing Strategy
22.3.2.6.2. Product Strategy
22.3.2.6.3. Channel Strategy
22.3.3. Advanced Molecular Diagnostics (AMD)
22.3.3.1. Overview
22.3.3.2. Product Portfolio
22.3.3.3. Key Financials
22.3.3.4. Sales Footprint
22.3.3.5. SWOT Analysis
22.3.3.6. Strategy Overview
22.3.3.6.1. Marketing Strategy
22.3.3.6.2. Product Strategy
22.3.3.6.3. Channel Strategy
22.3.4. Illumina Inc.
22.3.4.1. Overview
22.3.4.2. Product Portfolio
22.3.4.3. Key Financials
22.3.4.4. Sales Footprint
22.3.4.5. SWOT Analysis
22.3.4.6. Strategy Overview
22.3.4.6.1. Marketing Strategy
22.3.4.6.2. Product Strategy
22.3.4.6.3. Channel Strategy
22.3.5. Helvetica Healthcare
22.3.5.1. Overview
22.3.5.2. Product Portfolio
22.3.5.3. Key Financials
22.3.5.4. Sales Footprint
22.3.5.5. SWOT Analysis
22.3.5.6. Strategy Overview
22.3.5.6.1. Marketing Strategy
22.3.5.6.2. Product Strategy
22.3.5.6.3. Channel Strategy
22.3.6. Qiagen
22.3.6.1. Overview
22.3.6.2. Product Portfolio
22.3.6.3. Key Financials
22.3.6.4. Sales Footprint
22.3.6.5. SWOT Analysis
22.3.6.6. Strategy Overview
22.3.6.6.1. Marketing Strategy
22.3.6.6.2. Product Strategy
22.3.6.6.3. Channel Strategy
22.3.7. Jant Pharmacal Corporation
22.3.7.1. Overview
22.3.7.2. Product Portfolio
22.3.7.3. Key Financials
22.3.7.4. Sales Footprint
22.3.7.5. SWOT Analysis
22.3.7.6. Strategy Overview
22.3.7.6.1. Marketing Strategy
22.3.7.6.2. Product Strategy
22.3.7.6.3. Channel Strategy
22.3.8. Trivitron Healthcare
22.3.8.1. Overview
22.3.8.2. Product Portfolio
22.3.8.3. Key Financials
22.3.8.4. Sales Footprint
22.3.8.5. SWOT Analysis
22.3.8.6. Strategy Overview
22.3.8.6.1. Marketing Strategy
22.3.8.6.2. Product Strategy
22.3.8.6.3. Channel Strategy
22.3.9. Thermo Fisher Scientific
22.3.9.1. Overview
22.3.9.2. Product Portfolio
22.3.9.3. Key Financials
22.3.9.4. Sales Footprint
22.3.9.5. SWOT Analysis
22.3.9.6. Strategy Overview
22.3.9.6.1. Marketing Strategy
22.3.9.6.2. Product Strategy
22.3.9.6.3. Channel Strategy
22.3.10. Cepheid
22.3.10.1. Overview
22.3.10.2. Product Portfolio
22.3.10.3. Key Financials
22.3.10.4. Sales Footprint
22.3.10.5. SWOT Analysis
22.3.10.6. Strategy Overview
22.3.10.6.1. Marketing Strategy
22.3.10.6.2. Product Strategy
22.3.10.6.3. Channel Strategy
22.3.11. Bioneer Corporation
22.3.11.1. Overview
22.3.11.2. Product Portfolio
22.3.11.3. Key Financials
22.3.11.4. Sales Footprint
22.3.11.5. SWOT Analysis
22.3.11.6. Strategy Overview
22.3.11.6.1. Marketing Strategy
22.3.11.6.2. Product Strategy
22.3.11.6.3. Channel Strategy
22.3.12. BioFire Diagnostics (Biomerieux)
22.3.12.1. Overview
22.3.12.2. Product Portfolio
22.3.12.3. Key Financials
22.3.12.4. Sales Footprint
22.3.12.5. SWOT Analysis
22.3.12.6. Strategy Overview
22.3.12.6.1. Marketing Strategy
22.3.12.6.2. Product Strategy
22.3.12.6.3. Channel Strategy
22.3.13. Antylia Scientific Company
22.3.13.1. Overview
22.3.13.2. Product Portfolio
22.3.13.3. Key Financials
22.3.13.4. Sales Footprint
22.3.13.5. SWOT Analysis
22.3.13.6. Strategy Overview
22.3.13.6.1. Marketing Strategy
22.3.13.6.2. Product Strategy
22.3.13.6.3. Channel Strategy
22.3.14. Quidel Corporation
22.3.14.1. Overview
22.3.14.2. Product Portfolio
22.3.14.3. Key Financials
22.3.14.4. Sales Footprint
22.3.14.5. SWOT Analysis
22.3.14.6. Strategy Overview
22.3.14.6.1. Marketing Strategy
22.3.14.6.2. Product Strategy
22.3.14.6.3. Channel Strategy
22.3.15. DTPM
22.3.15.1. Overview
22.3.15.2. Product Portfolio
22.3.15.3. Key Financials
22.3.15.4. Sales Footprint
22.3.15.5. SWOT Analysis
22.3.15.6. Strategy Overview
22.3.15.6.1. Marketing Strategy
22.3.15.6.2. Product Strategy
22.3.15.6.3. Channel Strategy
22.3.16. Luminex Corporation (DiaSorin)
22.3.16.1. Overview
22.3.16.2. Product Portfolio
22.3.16.3. Key Financials
22.3.16.4. Sales Footprint
22.3.16.5. SWOT Analysis
22.3.16.6. Strategy Overview
22.3.16.6.1. Marketing Strategy
22.3.16.6.2. Product Strategy
22.3.16.6.3. Channel Strategy
22.3.17. Bio-Rad Laboratories.
22.3.17.1. Overview
22.3.17.2. Product Portfolio
22.3.17.3. Key Financials
22.3.17.4. Sales Footprint
22.3.17.5. SWOT Analysis
22.3.17.6. Strategy Overview
22.3.17.6.1. Marketing Strategy
22.3.17.6.2. Product Strategy
22.3.17.6.3. Channel Strategy
23. Assumptions and Acronyms Used
24. Research Methodology
Explore Healthcare Insights
View Reports
Molecular Respiratory Panels Market
